全球肉毒桿菌毒素市場：按類型、用途- 預測 2023-2030

全球肉毒桿菌毒素市場規模預計將以15.46%的複合年成長率大幅成長，到2023年將達到493,408萬美元，到2030年將達到13,516.74百萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球肉毒桿菌毒素市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解自家公司在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球肉毒桿菌毒素市場規模及預測是多少？

2.在預測期內，COVID-19 影響全球肉毒桿菌市場的阻礙因素和影響為何？

3. 在預測期內，全球肉毒桿菌毒素市場需要投資哪些產品/細分市場/應用/領域？

4.全球肉毒桿菌毒素市場的競爭策略是什麼？

5. 全球肉毒桿菌毒素市場的技術趨勢和法律規範是什麼？

6.全球肉毒桿菌毒素市場主要供應商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球肉毒桿菌毒素市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 非侵入性美容手術的數量正在增加
    • 越來越多的人開始注重自己的外表
    • 隨著人口高齡化的增加，對使皮膚看起來更年輕的治療的需求也增加。
  • 抑制因素
    • 手續費用相對昂貴
  • 機會
    • 產品核可和新產品發布的增加
    • 人們對肉毒毒素的治療和美容應用的認知不斷提高
  • 任務
    • 此過程可能產生的副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 肉毒桿菌毒素市場：依類型

• A型肉毒桿菌毒素
• A型肉毒桿菌毒素
• A型肉毒桿菌毒素
• 利馬肉毒桿菌B

第7章 肉毒桿菌毒素市場：依用途

• 為了美麗
• 治療性的
  • 眼瞼痙攣
  • 下肢痙攣的馬蹄足
  • 單側臉部痙攣
  • 膀胱過動症和神經源性膀胱
  • 原發性腋窩多汗症
  • 痙攣性發聲困難
  • 痙攣性斜頸
  • 斜視
  • 上肢和下肢痙攣

第8章 北美、南美肉毒桿菌毒素市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太地區肉毒桿菌毒素市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲肉毒桿菌毒素市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Botulinum Toxins Market is forecasted to grow significantly, with a projected USD 4,934.08 million in 2023 at a CAGR of 15.46% and expected to reach a staggering USD 13,516.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Botulinum Toxins Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Botulinum Toxins Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, and RimabotulinumtoxinB. The OnabotulinumtoxinA is projected to witness significant market share during forecast period.

Based on Application, market is studied across Aesthetic and Therapeutic. The Therapeutic is further studied across Blepharospasm, Equinus Foot Associated With Lower Limb Spasticity, Hemifacial Spasm, Overactive Bladder & Neurogenic Bladder, Primary Axillary Hyperhidrosis, Spasmodic Dysphonia, Spasmodic Torticollis, Strabismus, and Upper & Lower Limb Spasticity. The Aesthetic is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Botulinum Toxins Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Botulinum Toxins Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Botulinum Toxins Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Botulinum Toxins Market?

4. What is the competitive strategic window for opportunities in the Global Botulinum Toxins Market?

5. What are the technology trends and regulatory frameworks in the Global Botulinum Toxins Market?

6. What is the market share of the leading vendors in the Global Botulinum Toxins Market?

7. What modes and strategic moves are considered suitable for entering the Global Botulinum Toxins Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Botulinum Toxins Market, by Type, 2022 vs 2030
• 4.3. Botulinum Toxins Market, by Application, 2022 vs 2030
• 4.4. Botulinum Toxins Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of non-invasive cosmetic procedures
    • 5.1.1.2. Increasing individuals highly conscious of their appearance
    • 5.1.1.3. Rising aging population demand for procedures to make their skin look young
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the procedure
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing number of product approvals and launch of novel products
    • 5.1.3.2. Surging awareness of therapeutic and cosmetic application of botulinum toxin
  • 5.1.4. Challenges
    • 5.1.4.1. Probable side effects of the procedure
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Botulinum Toxins Market, by Type

• 6.1. Introduction
• 6.2. AbobotulinumtoxinA
• 6.3. IncobotulinumtoxinA
• 6.4. OnabotulinumtoxinA
• 6.5. RimabotulinumtoxinB

7. Botulinum Toxins Market, by Application

• 7.1. Introduction
• 7.2. Aesthetic
• 7.3. Therapeutic
  • 7.3.1. Blepharospasm
  • 7.3.2. Equinus Foot Associated With Lower Limb Spasticity
  • 7.3.3. Hemifacial Spasm
  • 7.3.4. Overactive Bladder & Neurogenic Bladder
  • 7.3.5. Primary Axillary Hyperhidrosis
  • 7.3.6. Spasmodic Dysphonia
  • 7.3.7. Spasmodic Torticollis
  • 7.3.8. Strabismus
  • 7.3.9. Upper & Lower Limb Spasticity

8. Americas Botulinum Toxins Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Botulinum Toxins Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Botulinum Toxins Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BOTULINUM TOXINS MARKET RESEARCH PROCESS
• FIGURE 2. BOTULINUM TOXINS MARKET SIZE, 2022 VS 2030
• FIGURE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. BOTULINUM TOXINS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. BOTULINUM TOXINS MARKET DYNAMICS
• FIGURE 8. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BOTULINUM TOXINS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 12. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BOTULINUM TOXINS MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BOTULINUM TOXINS MARKET SIZE, BY EQUINUS FOOT ASSOCIATED WITH LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BOTULINUM TOXINS MARKET SIZE, BY HEMIFACIAL SPASM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BOTULINUM TOXINS MARKET SIZE, BY OVERACTIVE BLADDER & NEUROGENIC BLADDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BOTULINUM TOXINS MARKET SIZE, BY PRIMARY AXILLARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC DYSPHONIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BOTULINUM TOXINS MARKET SIZE, BY STRABISMUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. BOTULINUM TOXINS MARKET SIZE, BY UPPER & LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 149. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 150. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 151. BOTULINUM TOXINS MARKET LICENSE & PRICING